Elisa Lazzari

1.4k total citations
39 papers, 1.1k citations indexed

About

Elisa Lazzari is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Elisa Lazzari has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 19 papers in Hematology and 15 papers in Immunology. Recurrent topics in Elisa Lazzari's work include interferon and immune responses (11 papers), Multiple Myeloma Research and Treatments (11 papers) and RNA regulation and disease (6 papers). Elisa Lazzari is often cited by papers focused on interferon and immune responses (11 papers), Multiple Myeloma Research and Treatments (11 papers) and RNA regulation and disease (6 papers). Elisa Lazzari collaborates with scholars based in United States, Italy and Canada. Elisa Lazzari's co-authors include Caroline A. Jefferies, Joan Ní Gabhann, Germana Meroni, Catriona Jamieson, Claire Wynne, Leslie Crews, Raffaella Chiaramonte, Rowan Higgs, Siobhán Smith and Nathaniel P. Delos Santos and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Elisa Lazzari

37 papers receiving 1.1k citations

Peers

Elisa Lazzari
Cailin E. Joyce United States
Kimberly D. Klarmann United States
Lies Geboes Belgium
Shuwei Jiang United States
Euan W. Baxter United Kingdom
T Kikuchi Japan
Cailin E. Joyce United States
Elisa Lazzari
Citations per year, relative to Elisa Lazzari Elisa Lazzari (= 1×) peers Cailin E. Joyce

Countries citing papers authored by Elisa Lazzari

Since Specialization
Citations

This map shows the geographic impact of Elisa Lazzari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Lazzari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Lazzari more than expected).

Fields of papers citing papers by Elisa Lazzari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Lazzari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Lazzari. The network helps show where Elisa Lazzari may publish in the future.

Co-authorship network of co-authors of Elisa Lazzari

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Lazzari. A scholar is included among the top collaborators of Elisa Lazzari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Lazzari. Elisa Lazzari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lazzari, Elisa, Rui Vitorino, Germana Meroni, et al.. (2025). Comprehensive ubiquitome analysis reveals persistent mitochondrial remodeling disruptions from doxorubicin-induced cardiotoxicity in aged CD-1 male mice. Archives of Toxicology. 99(6). 2447–2462.
2.
D’Ambrosio, Luigi, et al.. (2024). A unique missense mutation in the RING domain impairs MID1 E3 ubiquitin ligase activity and localisation and is associated with uncommon Opitz Syndrome-like signs. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(4). 167126–167126. 1 indexed citations
3.
Platonova, Natalia, Elisa Lazzari, M. Colombo, et al.. (2023). The Potential of JAG Ligands as Therapeutic Targets and Predictive Biomarkers in Multiple Myeloma. International Journal of Molecular Sciences. 24(19). 14558–14558. 1 indexed citations
4.
Lu, Xiong, et al.. (2021). TRIM32 and Malin in Neurological and Neuromuscular Rare Diseases. Cells. 10(4). 820–820. 9 indexed citations
5.
Zhou, Tianyuan, Elisa Lazzari, Luisa Ladel, et al.. (2021). Selective antisense oligonucleotide inhibition of human IRF4 prevents malignant myeloma regeneration via cell cycle disruption. Cell stem cell. 28(4). 623–636.e9. 38 indexed citations
6.
Lazzari, Elisa, et al.. (2021). Effectiveness of 3D-printed orthoses for traumatic and chronic hand conditions: A scoping review. PLoS ONE. 16(11). e0260271–e0260271. 28 indexed citations
7.
Ramalingam, Pradeep, Michael G. Poulos, Michael Gutkin, et al.. (2020). Endothelial mTOR maintains hematopoiesis during aging. The Journal of Experimental Medicine. 217(6). 25 indexed citations
8.
Ramalingam, Pradeep, Michael G. Poulos, Elisa Lazzari, et al.. (2020). Chronic activation of endothelial MAPK disrupts hematopoiesis via NFKB dependent inflammatory stress reversible by SCGF. Nature Communications. 11(1). 666–666. 54 indexed citations
9.
Lazzari, Elisa, et al.. (2019). Analysis of the Zn-Binding Domains of TRIM32, the E3 Ubiquitin Ligase Mutated in Limb Girdle Muscular Dystrophy 2H. Cells. 8(3). 254–254. 13 indexed citations
10.
Jiang, Qingfei, M Zipeto, Jessica Pham, et al.. (2019). Hyper-Editing of Cell-Cycle Regulatory and Tumor Suppressor RNA Promotes Malignant Progenitor Propagation. Cancer Cell. 35(1). 81–94.e7. 71 indexed citations
11.
Colombo, M., S. Garavelli, Natalia Platonova, et al.. (2019). Multiple myeloma exploits Jagged1 and Jagged2 to promote intrinsic and bone marrow-dependent drug resistance. Haematologica. 105(7). 1925–1936. 22 indexed citations
12.
Lazzari, Elisa & Jason M. Butler. (2018). The Instructive Role of the Bone Marrow Niche in Aging and Leukemia. Current Stem Cell Reports. 4(4). 291–298. 14 indexed citations
13.
Ma, Wenxue, Ping Chen, Qingfei Jiang, et al.. (2017). Telomerase Inhibition Impairs Self-Renewal of ß-Catenin Activated Myeloproliferative Neoplasm Progenitors. Blood. 130. 2860. 1 indexed citations
14.
Lazzari, Elisa, Nathaniel P. Delos Santos, Amber Miller, et al.. (2017). Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma. Nature Communications. 8(1). 1922–1922. 87 indexed citations
15.
Crews, Leslie, Larisa Balaian, Nathaniel P. Delos Santos, et al.. (2016). RNA Splicing Modulation Selectively Impairs Leukemia Stem Cell Maintenance in Secondary Human AML. Cell stem cell. 19(5). 599–612. 90 indexed citations
16.
Pineda, Gabriel, Kathleen M. Lennon, Nathaniel P. Delos Santos, et al.. (2016). Tracking of Normal and Malignant Progenitor Cell Cycle Transit in a Defined Niche. Scientific Reports. 6(1). 23885–23885. 4 indexed citations
17.
Lazzari, Elisa & Germana Meroni. (2016). TRIM32 ubiquitin E3 ligase, one enzyme for several pathologies: From muscular dystrophy to tumours. The International Journal of Biochemistry & Cell Biology. 79. 469–477. 51 indexed citations
18.
Lazzari, Elisa & Caroline A. Jefferies. (2014). IRF5-mediated signaling and implications for SLE. Clinical Immunology. 153(2). 343–352. 45 indexed citations
19.
Wynne, Claire, Elisa Lazzari, Siobhán Smith, et al.. (2014). TRIM68 Negatively Regulates IFN-β Production by Degrading TRK Fused Gene, a Novel Driver of IFN-β Downstream of Anti-Viral Detection Systems. PLoS ONE. 9(7). e101503–e101503. 17 indexed citations
20.
Mirandola, Leonardo, M. Colombo, Yiting Yu, et al.. (2013). Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4/SDF-1. Leukemia. 27(7). 1558–1566. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026